Search
for
Sort by
Research 31–60 of 1000+
- Establishment of an Efficient Primary Culture System for Human Hair Follicle Stem Cells Using the Rho-Associated Protein Kinase Inhibitor Y-27632
- Phosphatidylinositol 3-Kinase/Akt-Dependent and -Independent Protection Against Apoptosis in Normal Human Melanocytes
- The Critical Roles of Serum/Glucocorticoid-Regulated Kinase 3 (SGK3) in the Hair Follicle Morphogenesis and Homeostasis
- In Ovo Injection of CHIR-99021 Promotes Feather Follicle Development via Modulating the Wnt Signaling Pathway and Transcriptome in Goose Embryos (Anser cygnoides)
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The Role of Janus Kinase Inhibitors in Dermatology
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
- Anti-Hair Loss Effect of Adenosine Is Exerted by cAMP Mediated Wnt/β-Catenin Pathway Stimulation via Modulation of Gsk3β Activity in Cultured Human Dermal Papilla Cells
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- The PDGF/PDGFR pathway as a drug target
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The JAK/STAT signaling pathway: from bench to clinic
- Two distinct signaling pathways in hair cycle induction: Stat3-dependent and -independent pathways
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation
- The role of janus kinases in the treatment of autoimmune skin diseases
- Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata
- Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Integrated miRNA-mRNA analysis reveals regulatory pathways underlying the curly fleece trait in Chinese tan sheep
- Acne inversa-like lesions associated with the multi-kinase inhibitor sorafenib
- Identification of key genes and signaling pathways related to Hetian sheep wool density by RNA-seq technology